Replies to post #22985 on Don't Bite The Hand That Feeds You

[investorwisdom]

I noticed on your profile you like DNDN well CVM claims to have a better version that is more effective of the same type of cancer drug. Which means CVM has the potential to be a $50 + stock. I thought you would like it. Do a little investigation, you will see what I'm talking about...